Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Letter

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus

Authors

M D de Kruif PubMed articles Google scholar articles
M Limper PubMed articles Google scholar articles
H R Hansen PubMed articles Google scholar articles
J de Ruiter PubMed articles Google scholar articles
C A Spek PubMed articles Google scholar articles
E C M van Gorp PubMed articles Google scholar articles
I J ten Berge PubMed articles Google scholar articles
A T Rowshani PubMed articles Google scholar articles
H ten Cate PubMed articles Google scholar articles
E W Meesters PubMed articles Google scholar articles

Correspondence to Dr M D de Kruif, Department of Internal Medicine, Slotervaart Hospital, Louwesweg 6, 1066 EC Amsterdam, The Netherlands; m.d.dekruif{at}amc.uva.nl

Citation

de Kruif MD, Limper M, Hansen HR, et al

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus

Annals of the Rheumatic Diseases 2009;68:1654.

Publication history

Accepted April 21, 2009
First published September 11, 2009.

Online issue publication

April 13, 2016

Copyright information

BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.